MDXH Competitors & Alternatives
Compare MDxHealth SA ADR with similar stocks in the same industry
Diagnostics & Research
MDXH
Main Stock$0.54
Tradestie Score
53
Market Cap
$231.40M
Revenue Growth
0.1%
Analyst Upside
+439.8%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$10.49
|
$1.13B | - | 58 | Compare |
|
CDNA
CareDx, Inc.
|
$23.25
|
$798.40M | - | 62 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$17.99
|
$719.31M | - | 45 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$20.46
|
$667.77M | - | 64 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$9.69
|
$612.76M | - | 56 | Compare |
|
NYXH
Nyxoah SA Ordinary Shares
|
$1.58
|
$185.47M | - | 42 | Compare |
|
MOLN
Molecular Partners AG American Depositary Shares
|
$3.92
|
$138.88M | - | 57 | Compare |
|
SERA
Sera Prognostics, Inc. Class A Common Stock
|
$1.86
|
$112.28M | - | 52 | Compare |
|
LUCD
Lucid Diagnostics Inc. Common Stock
|
$1.02
|
$103.93M | - | 57 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$15.33
|
$61.36M | - | 52 | Compare |
More MDXH Analysis
Data updated: Jun 16, 2026 | Industry: Diagnostics & Research (SIC 8071)
39 stocks in this industry